Last updated on November 2017

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine


Brief description of study

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine

Detailed Study Description

The purpose of this clinical trial is to determine whether an investigational treatment, when added to either rituximab or cyclophosphamide, can improve your vasculitis disease activity, kidney function, and/or quality of life.

Clinical Study Identifier: TX15436

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

ANITA FARHI, RN

NYU Winthrop Hospital, Clinical Research Center
Mineola, NY USA
  Connect »